🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

FMT in Initial CDI

RecruitingNAAges 18 Years - 120 YearsAllTurku University Hospital
NCT05257538 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study explores fecal microbiota transfer via retention enema after the first clostridioides difficile episode.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * \>18 years * C. difficile PCR in feces positive and clinical symptoms of enteritis. * Full resolution of diarrhea during antibiotic treatment for C. difficile * No other ongoing antibacterial treatments. * No ongoing probiotics. * Signed informed consent. Exclusion Criteria: * Pregnant * Ongoing need for antibacterial treatment * Life expectancy \< 1 year * Prior C. difficile infection in preceding 3 months * Unable to provide written consent, due to dementia for example. * Fecal incontinence i.e. inability to retain enema.
💊

What it tests

  • FMT
  • placebo enema
📍

Where

1 site
Turku University hospital
Turku, Finland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy